Table 3.
Gender-specific subject distribution of clinical variables
| Mean ± SD, mmol/l | Reading, mmol/l (range) | n | Treatment adherence, % |
|||
|---|---|---|---|---|---|---|
| low | normal | high | ||||
| Cholesterol | 4.9 ± 1.2 | 2.5 − 8.9 | 200 | 1.5 | 66.5 | 32 |
| Males | 5.1 ± 1.4 | 2.5 − 8.9 | 63 | 3.2 | 54 | 42.9 |
| Females | 4.8 ± 1 | 2.6 − 7.7 | 137 | 0.7 | 72.3 | 27 |
| Triglycerides | 1.8 ± 2.5 | 0.34 − 35.1 | 197 | 0.5 | 80.2 | 19.3 |
| Males | 2.4 ± 4.3 | 0.50 − 35.1 | 62 | 0 | 69.4 | 30.6 |
| Females | 1.5 ± 0.8 | 0.34 − 6.4 | 135 | 0.7 | 85.2 | 14.1 |
| HDL | 1.3 ± 0.3 | 0.57 − 2.6 | 180 | 20 | 77.2 | 2.8 |
| Males | 1 ± 0.2 | 0.68 − 1.7 | 55 | 40 | 60 | 0 |
| Females | 1.3 ± 0.3 | 0.57 − 2.6 | 125 | 11.2 | 84.8 | 4 |
| LDL | 2.9 ± 1 | 0.7 − 6 | 178 | 43.2 | 32.4 | 24.4 |
| Males | 3 ± 1.2 | 0.7 − 5.8 | 53 | 34.6 | 30.8 | 34.6 |
| Females | 2.8 ± 0.96 | 1.3 − 6 | 125 | 46.8 | 33.1 | 20.2 |
| VLDL | 0.8 ± 1.4 | 0.14 − 14.1 | 101 | 39.6 | 58.4 | 2 |
| Males | 1.3 ± 2.6 | 0.26 − 14.1 | 27 | 25.9 | 70.4 | 3.7 |
| Females | 0.7 ± 0.4 | 0.14 − 2.9 | 74 | 44.6 | 54.1 | 1.4 |